Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 92, Issue 3, Pages 291-303Publisher
SPRINGER
DOI: 10.1007/s00109-013-1104-3
Keywords
S100A6.; HCC.; Proliferation.; Migration.; Tumorigenesis
Funding
- National Natural Sciences Foundation of China [30900768]
- National 973 Basic Research Program of China [2010CB529900, 2011CB910703]
Ask authors/readers for more resources
High levels of S100A6 have been associated with poor outcome in some types of human cancers, but the role of S100A6 in the molecular pathogenesis of these cancers is largely unknown. This study was performed to explore the expression and functional roles of S100A6 in hepatocellular carcinoma (HCC). The expression level of S100A6 in HCC tumor and corresponding peritumoral tissues were determined by immunohistochemistry analysis. The potential functions of S100A6 in tumorigenesis and metastasis were analyzed by cell proliferation, migration, and invasion assays in human liver cancer cells. Moreover, through expression and purification of S100A6 recombinant protein tagged with cell-penetrating peptide, we analyzed its complex extracellular/intracellular effects in a S100A6-silenced cellular model. As a result, the expression of S100A6 was up-regulated in human HCC compared with adjacent peritumoral tissues. S100A6 silencing inhibited the growth and motility of HCC cells, while intracellular re-expression of S100A6 could rescue the proliferation and migration defects. Intracellular overexpression of S100A6 resulted in down-regulation of E-cadherin expression and promoted nuclear accumulation of beta-catenin. Moreover, we found that the enhanced cell proliferation and motility after S100A6 stimulation were dependent on the activation of PI3K/ AKT pathway. These results suggest that S100A6 may be involved in promotion and progression of human liver cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available